Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06763562 · ClinicalTrials.gov registry record · NA

Food Orders on Blood Glucose and Fuel Use At Rest

A NA study of Glucose Metabolism Disorders and Hunger, sponsored by Old Dominion University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06763562: Recruiting NA study of Glucose Metabolism Disorders and Hunger, sponsored by Old Dominion University.

NCT06763562 is a NA study of Glucose Metabolism Disorders and Hunger that is actively recruiting participants, run by Old Dominion University. The registered enrollment target is 60 participants, below the 226-participant average among 14 other Glucose Metabolism Disorders trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06763562, a NA study of Glucose Metabolism Disorders and Hunger, is actively recruiting participants, sponsored by Old Dominion University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Consuming a carbohydrate-rich food as the final food in a meal, as compared to the first food in a meal, has been shown to reduce blood glucose levels after eating in both diabetes patients and in healthy controls. However, gaps remain in the literature in this area of research, and currently little is known about how substrate (fuel) use is impacted by altering food order. In addition, most studies to date have used a mix of meat and plant foods, while little research has focused exclusively on vegetarian foods. This randomized experiment will examine how altering the order of foods eaten in a vegetarian meal impacts blood glucose and fuel utilization at rest.

Primary Outcome

Ratio of carbon dioxide production and oxygen consumption for determination of fuel use

Interventions

  • OTHER Carbohydrate-first meal
  • OTHER Carbohydrate-last meal

Study Locations (1)

Virginia

  • Old Dominion University Human Performance Laboratory - Norfolk

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-01-05
Est. Completion 2026-06-30
Phase NA
Old Dominion University

23 total trials

What NCT06763562 shows while recruiting

NCT06763562 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 226-participant average among 14 other Glucose Metabolism Disorders trials with a reported enrollment target (73% lower).

The record links to 3 conditions, with Glucose Metabolism Disorders appearing as the primary indexed condition, and to 2 interventions - of which Carbohydrate-first meal is the first listed.

NCT06763562 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT06763562 about?

NCT06763562 is a clinical study titled "Food Orders on Blood Glucose and Fuel Use At Rest". Consuming a carbohydrate-rich food as the final food in a meal, as compared to the first food in a meal, has been shown to reduce blood glucose levels after eating in both diabetes patients and in healthy controls. However, gaps remain in the literature in this area of research, and currently little...

What is the current status of trial NCT06763562?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-01-05. Estimated completion is 2026-06-30.

What conditions does trial NCT06763562 study?

This clinical trial studies the following conditions: Glucose Metabolism Disorders, Hunger, Fat Burn.

What interventions are being tested in trial NCT06763562?

The interventions under investigation include: Carbohydrate-first meal (OTHER), Carbohydrate-last meal (OTHER).

Who is sponsoring clinical trial NCT06763562?

This trial is sponsored by Old Dominion University, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06763562 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glucose Metabolism Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06763562's enrollment target sits among peer trials

60 9th of 14 higher than 5 of 14 other Glucose Metabolism Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Glucose Metabolism Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06763562, the US trial registry maintained by the National Library of Medicine. NCT06763562 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.